Hepatitis in growth promoter treated cows

Journal of Veterinary Medicine Series A: Physiology Pathology Clinical Medicine

Volumn 49, Issue 9, 2002, Pages 466-469

  Groot, M J ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; STANOZOLOL;

ANIMAL; ANIMAL DISEASE; ARTICLE; CATTLE; CATTLE DISEASE; CHEMICALLY INDUCED DISORDER; FEMALE; INDUSTRY; LEGAL ASPECT; LIVER; MEAT; NETHERLANDS; PATHOLOGY; TOXIC HEPATITIS; URINE;

ANABOLIC AGENTS; ANIMALS; CATTLE; CATTLE DISEASES; FEMALE; HEPATITIS, TOXIC; INDUSTRY; LIVER; MEAT; NETHERLANDS; STANOZOLOL;

EID: 0036832617     PISSN: 0931184X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1439-0442.2002.00477.x     Document Type: Article

References (31)

1. Abu-Shakra, S., M. S. Alhalabi, F. C. Nachtman, R. A. Schemidt, and W. S. Brusilow, 1997: Anabolic steroids induce injury and apoptosis of differentiated skeletal muscle. J. Neurosci. Res. 47, 186-197.
2. Balazs, M., 1988: Sinusoidal dilatation of the liver in patients on oral contraceptives. Electron microscopical study of 14 cases Exp. Pathol. 35, 231-237.
3. Blue, J. G., and J A Lombardo, 1999: Steroids and steroid-like compounds Clinics Sports Med 18, 667-689.
4. Boada, L. D., M. Zumbado, S. Torres, A. Lopez, B N. Diaz-Chico, J. J. Cabrera, and O P Luzardo. 1999: Evaluation of acute and chronic hepatotoxic effects exerted by anabolic-androgenic steroid stanozolol in adult male rats. Arch Toxicol. 73, 465-472.
5. Catlin, D. 1995: Anabolic steroids p2362-2376. In. De Groot, L. J. (ed ), Endocrinology. Saunders and Co., Philadelphia.
6. Chitturi, S., and G. C. Farrel, 2001: Drug-induced cholestasis. Semin. Gastrointest. Dis. 12, 113-124.
7. Creagh, T. M., A. Rubin, and D J. Evans, 1988. Hepatic tumours induced by anabolic steroids in an athlete. J. Clin. Pathol. 41, 441-443
8. Dossing, M., and J. Sonne, 1993. Drug-induced hepatic disorders. Incidence management and avoidance Drug Safety 9, 441-449
9. Goldfarb, S., 1976. Sex hormones and hepatic neoplasia Cancer Res. 36, 2584-2588.
10. Graham, S , and M. Kennedy, 1990. Recent developments in toxicology of anabolic steroids. Drug safety 5, 458-476.
11. Gurakar, A., P. Caraceni, S. Fagiuoli, and D H. Van Thiel, 1994: Androgenic anabolic steroid-induced intrahepatic cholestasis: a review with four additional case reports. J. Okla State Med. Assoc. 87, 399-404
12. Handelsman, D. J.. 1995: Testosterone and other androgens: physiology, pharmacology and therapeutic use. In: De Groot, L. J. (ed.), Endocrinology, pp. 2351-2361. Saunders & Co., Philadelphia.
13. Harkin, K. R., L. A Cowan, G A. Andrews, R. J. Basaraba. J. R. Fischer, L. J. Debowes, J. K. Roush, M. L. Guglielmino, and C. A. Kirk, 2000: Hepatotoxicity of stanozolol in cats. J. Am. Vet. Med. Assoc. 27, 681-641.
14. Heywood, R., H. Chesterman. S. A. Ball, and P. F. Wadsworth, 1977: Toxicity of methyl testosterone in the beagle dog. Toxicology 7, 357-365.
15. Ishak, K. G., 1979: Hepatic neoplasms associated with contraceptive and anabolic steroids In: Lingeman, C. H. (ed.). Carcinogenic Hormones, pp. 74-128. Springer Verlag, New York.
16. Johnson, F. L., K. C. Lerner, M Siegel, J. F. Feagler, P. W. Majerus, J. R. Hartmann, and E. D. Thomas, 1972: Association of androgenic-anabolic steroid therapy with the development of hepatocellular carcinoma. Lancet 16, 1273-1276
17. Jubb, K V. F., P. C. Kennedy, and N. Palmer, 1993: Pathology of Domestic Animals, 4th edn. Academic Press, New York.
18. Knopp, W. D.. T. W Wang, and B. R. Bach, 1997: Ergogenic drugs in sports. Clinics Sports Med. 16, 375-392.
19. Lesna, M., and W Taylor, 1986: Liver lesions in Balb/C mice induced by an anabolic androgen (decadurabolin). with and without pretreatment with diethylnitrosamine. J. Steroid Biochem 24, 449-453.
20. Nadell, J., and J. Kosek, 1977: Peliosis hepatis, twelve cases associated with oral androgen therapy. Arch. Pathol. Lab. Med. 101, 405-410.
21. Seawright, A. A., 1984: Phlebectatic peliosis hepatis in Australian cattle. Vet Hum. Tox. 26, 208-213.
22. Sheffer, A. L., D. T. Fearon, and K. F. Austen, 1987: Hereditary angioedema: a decade of management with stanozolol. J. Allergy Clin. Immunol. 80, 855-860.
23. Soe, K L., M Soe, and C. Gluud. 1992: Liver pathology associated with the use of anabolic androgenic steroids. Liver 12, 73-79.
24. Stang-Vos, C., and H. J. Appell, 1981. Structural alterations of liver parenchyma induced by anabolic steroids. Int. J. Sports Med. 2, 101-105.
25. Strazzabosco, M., C Spirli, and L. Okolicsanyi, 2000: Pathophysiology of the intrahepatic biliary epithelium. J. Gastrenterol. Hepatol. 15, 244-253
26. Thein, L., J. Thein, and G. Landry, 1995: Ergogenic aids. Phys. Ther. 75, 95-108.
27. Turani, H., J. Levi, D. Zevin, and E. Kessler, 1983: Hepatic lesions in patients on anabolic androgen therapy. Isr. J. Med. Sci. 19, 332-337.
28. Wakabayashi, T., H. Onda, T. Tada, M. Iijima, and Y. Itoh, 1984: High incidence of peliosis hepatis in autopsy cases of aplastic anemia with special reference to anabolic steroid therapy. Acta Pathol. Jpn. 34, 1079-1086.
29. Welder, A. A., J. W Robertson, and R. B. Melchert, 1995: Toxic effects of anabolic-androgenic steroids in primary rat hepatic cell cultures. J. Pharmacol. Toxicol. Meth. 33, 187-195.
30. Yoshida, T., J. H Klinkspoor, R Kuver, M. Poot, P. S. Rabinoviteh, S P Wrenn, E. W. Kaler, and S. P. Lee, 2001: Effects of bile salts on cholestan-3beta.5alpha.6beta-triol-induced apoptosis in dog gallbladder epithelial cells. Biochim. Biophys. Acta 26, 199-208.
31. Yosida, E. M., M. A. Karim, J. F. Shaikh, J. G. Soos, and S. E Erb, 1994: At what price, glory? Severe cholestasis and acute renal failure in an athlete abusing stanozolol. Can. Med. Assoc J 151, 791-793.